Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Alpha Tau Medical Ltd. - Ordinary Shares (NQ: DRTS ) 2.240 UNCHANGED Streaming Delayed Price Updated: 3:58 PM EST, Nov 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 112 Open 2.240 Bid (Size) 2.210 (1) Ask (Size) 2.240 (7) Prev. Close 2.240 Today's Range 2.240 - 2.240 52wk Range 1.750 - 3.400 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme October 21, 2024 From Alpha Tau Medical Ltd. Via GlobeNewswire Alpha Tau Treats First Patient with Recurrent Lung Cancer October 10, 2024 From Alpha Tau Medical Ltd. Via GlobeNewswire Performance YTD -25.33% -25.33% 1 Month -2.18% -2.18% 3 Month +8.21% +8.21% 6 Month -9.31% -9.31% 1 Year -27.97% -27.97% More News Read More Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC September 20, 2024 From Alpha Tau Medical Ltd. Via GlobeNewswire Expert Ratings for Alpha Tau Medical December 15, 2023 Via Benzinga Analyst Ratings for Alpha Tau Medical November 17, 2023 Via Benzinga DRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q2 2024 August 14, 2024 Via InvestorPlace Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers June 25, 2024 From Alpha Tau Medical Ltd. Via GlobeNewswire DRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q1 2024 May 20, 2024 Via InvestorPlace Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer May 13, 2024 From Alpha Tau Medical Ltd. Via GlobeNewswire DRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q4 2023 March 07, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's After-Market Session January 10, 2024 Via Benzinga Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference December 20, 2023 From Alpha Tau Medical Ltd. Via GlobeNewswire Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer November 28, 2023 From Alpha Tau Medical Ltd. Via GlobeNewswire Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer November 20, 2023 From Alpha Tau Medical Ltd. Via GlobeNewswire Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing Facility October 30, 2023 From Alpha Tau Medical Ltd. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's After-Market Session October 25, 2023 Via Benzinga Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory Board October 24, 2023 From Alpha Tau Medical Ltd. Via GlobeNewswire Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel’s Hadassah Medical Center September 14, 2023 From Alpha Tau Medical Ltd. Via GlobeNewswire Why Alpha Tau Medical Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket August 29, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session August 25, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session August 21, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session August 18, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday August 18, 2023 Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session August 17, 2023 Via Benzinga Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT August 17, 2023 From Alpha Tau Medical Ltd. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
